{"id":3230,"count":51,"description":"Catalogul principal MedsBase pentru diabet grupeaz\u0103 toate medicamentele pentru diabet din clasele majore de medicamente. Detalierea clinic\u0103 pe familii de molecule cu lista complet\u0103 de m\u0103rci se g\u0103se\u0219te \u00een <a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\">Medicamente pentru diabet<\/a> subcategoria noastr\u0103 \u2014 v\u0103 rug\u0103m s\u0103 naviga\u021bi acolo pentru ghidare de selec\u021bie \u0219i context de dozare. Toate produsele sunt furnizate de <strong>produc\u0103tori certifica\u021bi WHO-GMP<\/strong>.\n\n<strong>Rezumat pe clase de medicamente.<\/strong> Biguanide (metformin \u2014 de prim\u0103 linie, Glycomet SR, Metford), sulfoniluree (gliclazid\u0103, glimepirid\u0103, glibenclamid\u0103, glipizid\u0103), inhibitori DPP-4 (sitagliptin Januvia, vildagliptin Galvus, saxagliptin Onglyza, linagliptin Trajenta, teneligliptin Ziten), inhibitori SGLT-2 (dapagliflozin Forxiga, empagliflozin Jardiance, canagliflozin Invokana \u2014 cu beneficii cardio-renale), pioglitazon\u0103 (Pioz), meglitinide (repaglinid\u0103 Novonorm, nateglinid\u0103 Glinate), inhibitori alfa-glucosidaz\u0103 (acarbaz\u0103 Glucobayay, vogliboz\u0103 Voglibite, miglitol Mignar) \u0219i insuline rapide \u00een stilouri (insulin\u0103 aspart Novorapid Flexpen, insulin\u0103 glulisin\u0103 Apidra SoloStar). Terapiile combinate care asociaz\u0103 metformin\u0103 cu sulfoniluree, inhibitor DPP-4 sau inhibitor SGLT-2 reduc num\u0103rul de comprimate la pacien\u021bii cu polifarmacie.\n\n<strong>Agente specializate.<\/strong> Lipaglyn (saroglitazar \u2014 agonist dual PPAR \u03b1\/\u03b3 pentru dislipidemia diabetic\u0103 \u0219i NASH) ca <a href=\"https:\/\/medsbase.com\/ro\/lipaglyn\/\">Lipaglyn<\/a>. Metilcobalamin\u0103\/cianocianocobalamin\u0103 injectabil\u0103 pentru neuropatia diabetic\u0103 ca <a href=\"https:\/\/medsbase.com\/ro\/methycobal-injection\/\">Injectie Methycobal<\/a>.\n\n<strong>Ce NU este aici.<\/strong> Agoni\u0219tii receptorilor GLP-1 (semaglutid\u0103 Ozempic, liraglutid\u0103 Victoza, dulaglutid\u0103, tirzepatid\u0103) sunt stocate separat ca parte a comenzii noastre de gestionare a greut\u0103\u021bii \u2014 vezi <a href=\"https:\/\/medsbase.com\/ro\/how-to-get-ozempic-for-weight-loss\/\">Cele mai bune alternative la Ozempic pentru 2026<\/a>. Insulinele bazale cu ac\u021biune \u00eendelungat\u0103 (insulin\u0103 glargin\u0103, degludec, detemir) sunt listate \u00een subcategorii dedicate pentru insulin\u0103, acolo unde sunt disponibile.\n\n<strong>Dezambiguizare.<\/strong> Desmopresin\u0103 (comprimate Minirin, spray nazal Minirin) este \u00een prezent listat\u0103 gre\u0219it \u00een catalogul nostru de diabet. Desmopresina trateaz\u0103 diabetul <strong>insipid<\/strong> (o afec\u021biune renal\u0103 de gestionare a apei) \u0219i enureza nocturn\u0103\/nocturia \u2014 NU diabetul <strong>zaharat<\/strong> (tipul comun de diabet tip 1\/tip 2). Paginile clarific\u0103 acest lucru \u00een mod explicit. V\u0103 rug\u0103m s\u0103 muta\u021bi \u00een categoria vezico-prostatic\u0103\/urologic\u0103 odat\u0103 ce exist\u0103 o categorie dedicat\u0103 enurezei.\n\n<strong>Cum s\u0103 alegi.<\/strong> Diabetul tip 2 diagnostic nou \u2192 metformin\u0103 de prim\u0103 linie (titrat\u0103 la 1,5\u20132 g\/zi \u00een doze divizate). Control inadecvat sub metformin\u0103 \u2192 ad\u0103uga\u021bi inhibitor SGLT-2 (beneficiu cardio-renal) sau inhibitor DPP-4 (neutru din punct de vedere al greut\u0103\u021bii) sau sulfoniluree (cel mai ieftin, risc de hipoglicemie). Boal\u0103 cardiovascular\u0103 stabilit\u0103 sau insuficien\u021b\u0103 cardiac\u0103 \u2192 inhibitor SGLT-2 preferat indiferent de HbA1c. Exces semnificativ de greutate \u2192 SGLT-2 sau agonist GLP-1. Ris de hipoglicemie (v\u00e2rstnici, fragili, singuri) \u2192 evita\u021bi sulfonilureele, prefera\u021bi inhibitori DPP-4 sau SGLT-2. Diabet tip 1 \u2192 regim insulinic basal-bolus (ini\u021biat de specialist, nu catalogat aici).\n\n<strong>Important.<\/strong> Hiperglicemie brusc\u0103 cu grea\u021b\u0103, v\u0103rs\u0103turi, dureri abdominale \u2192 verifica\u021bi cetoacidoza diabetic\u0103 (mai ales la tipul 1 sau utilizator de SGLT-2 inhibitor), evaluare urgent\u0103. Hipoglicemie sever\u0103 cu nivel sc\u0103zut de con\u0219tien\u021b\u0103 \u2192 glucoz\u0103\/glucagon, 999. Diagnostic nou sau modificare semnificativ\u0103 a controlului necesit\u0103 monitorizare HbA1c la 3 luni. Stilul de via\u021b\u0103 (diet\u0103, greutate, activitate, renun\u021barea la fumat, controlul TA \u0219i al lipidelor) r\u0103m\u00e2ne baza \u00eentregii \u00eengrijiri pentru diabet.\n\nToate produsele MedsBase pentru Diabet se expediaz\u0103 din <strong>produc\u0103tori certifica\u021bi WHO-GMP<\/strong> cu ambalaj discret \u0219i sunt acoperite de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>.\n\n<!-- mb-hub-link --><strong>Ghidul cump\u0103r\u0103torului 2026:<\/strong> Vede\u021bi lista noastr\u0103 scurt\u0103 <a href=\"\/ro\/best-diabetes-medications-2026\/\">Cele mai bune medicamente pentru diabet 2026: Top 10 op\u021biuni comparate<\/a> pentru alegeri clasate, tabel comparativ, note de dozare \u0219i scurt\u0103tur\u0103 de decizie.","link":"https:\/\/medsbase.com\/ro\/diabetes\/","name":"Diabet","slug":"diabetes","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product?product_cat=3230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}